A123330 Stock Overview
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Genic Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩3,365.00 |
52 Week High | ₩5,470.00 |
52 Week Low | ₩3,150.00 |
Beta | 0.87 |
1 Month Change | -11.45% |
3 Month Change | -9.05% |
1 Year Change | -34.28% |
3 Year Change | -55.07% |
5 Year Change | -64.58% |
Change since IPO | -88.34% |
Recent News & Updates
Shareholder Returns
A123330 | KR Personal Products | KR Market | |
---|---|---|---|
7D | 1.5% | -0.7% | -0.4% |
1Y | -34.3% | -2.9% | 4.5% |
Return vs Industry: A123330 underperformed the KR Personal Products industry which returned -2.9% over the past year.
Return vs Market: A123330 underperformed the KR Market which returned 4.5% over the past year.
Price Volatility
A123330 volatility | |
---|---|
A123330 Average Weekly Movement | 5.2% |
Personal Products Industry Average Movement | 5.4% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.8% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A123330 has not had significant price volatility in the past 3 months.
Volatility Over Time: A123330's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 204 | Hyun-ho Yoo | www.genic21.com |
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands.
Genic Co., Ltd. Fundamentals Summary
A123330 fundamental statistics | |
---|---|
Market cap | ₩23.07b |
Earnings (TTM) | -₩4.41b |
Revenue (TTM) | ₩28.07b |
0.8x
P/S Ratio-5.2x
P/E RatioIs A123330 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A123330 income statement (TTM) | |
---|---|
Revenue | ₩28.07b |
Cost of Revenue | ₩24.84b |
Gross Profit | ₩3.23b |
Other Expenses | ₩7.64b |
Earnings | -₩4.41b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -643.32 |
Gross Margin | 11.52% |
Net Profit Margin | -15.71% |
Debt/Equity Ratio | 60.7% |
How did A123330 perform over the long term?
See historical performance and comparison